Funded Tech Companies
NephroGenex
Looking for the VC firms that provided funding to NephroGenex? Healthcap Venture Capital, Care Capital and Rho Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
NephroGenex
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3200 Beechleaf Ct. 900
Raleigh, NC 27604
USA
Raleigh, NC 27604
USA
Phone
Website
Email Address
Company Background Information
Overview
NephroGenex (NASDAQ: NRX) is a biotechnology company applying the latest advances in molecular profiling technologies to unravel the complex pathologies found in kidney disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/11/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Isdale
Company Investors
- Healthcap Venture Capital (Eugen Steiner)
- Care Capital (Richard Markham)
- Rho Ventures
Browse more funded tech companies:
NephroDI Therapeutics | Nephron Pharmaceuticals
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs